Literature DB >> 8046346

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils.

S Takanaski1, R Nonaka, Z Xing, P O'Byrne, J Dolovich, M Jordana.   

Abstract

In this study we have investigated the effects of interleukin 10 (IL-10) on human peripheral blood eosinophils stimulated with granulocyte/macrophage colony stimulating factor (GM-CSF) and lipopolysaccharide (LPS). We show that LPS was able to enhance eosinophil survival in a dose-dependent manner, as well as release of the cytokines GM-CSF, tumor necrosis factor alpha, and IL-8. LPS-induced eosinophil survival was largely inhibited by an anti-GM-CSF neutralizing antibody and completely blocked by polymyxin B, suggesting GM-CSF involvement in the survival enhancing mechanism and LPS specificity, respectively. IL-10 significantly inhibited survival of, and cytokine production from, eosinophils induced by LPS, but did not inhibit the survival induced by GM-CSF. These observations suggest a novel activation mechanism of eosinophils and, also, that IL-10 may participate in the regulation of diseases characterized by eosinophil infiltration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046346      PMCID: PMC2191606          DOI: 10.1084/jem.180.2.711

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

Review 1.  Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages.

Authors:  J M Cavaillon; N Haeffner-Cavaillon
Journal:  Cytokine       Date:  1990-09       Impact factor: 3.861

2.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.

Authors:  T T Hansel; I J De Vries; T Iff; S Rihs; M Wandzilak; S Betz; K Blaser; C Walker
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

3.  Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1).

Authors:  I Ohno; R G Lea; K C Flanders; D A Clark; D Banwatt; J Dolovich; J Denburg; C B Harley; J Gauldie; M Jordana
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  Human eosinophils synthesize and secrete interleukin-6, in vitro.

Authors:  Q Hamid; J Barkans; Q Meng; S Ying; J S Abrams; A B Kay; R Moqbel
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

5.  Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis.

Authors:  I Ohno; R Lea; S Finotto; J Marshall; J Denburg; J Dolovich; J Gauldie; M Jordana
Journal:  Am J Respir Cell Mol Biol       Date:  1991-12       Impact factor: 6.914

6.  Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.

Authors:  D H Broide; M M Paine; G S Firestein
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

7.  Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore.

Authors:  R K Braun; M Franchini; F Erard; S Rihs; I J De Vries; K Blaser; T T Hansel; C Walker
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

Review 8.  Mechanisms of eosinophil recruitment.

Authors:  M B Resnick; P F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  1993-04       Impact factor: 6.914

9.  IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor.

Authors:  P Ralph; I Nakoinz; A Sampson-Johannes; S Fong; D Lowe; H Y Min; L Lin
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

10.  Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.

Authors:  R Moqbel; Q Hamid; S Ying; J Barkans; A Hartnell; A Tsicopoulos; A J Wardlaw; A B Kay
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Mechanisms of interleukin-10-mediated immune suppression.

Authors:  C A Akdis; K Blaser
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

Review 2.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid.

Authors:  Kadriye Erkan; Mete K Bozkurt; Hasibe Artaç; Hülya Özdemir; Ali Ünlü; Emine N Korucu; Çağdaş Elsürer
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-28       Impact factor: 2.503

4.  Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous.

Authors:  Robert J Freishtat; Alan M Watson; Angela S Benton; Sabah F Iqbal; Dinesh K Pillai; Mary C Rose; Eric P Hoffman
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-12       Impact factor: 6.914

5.  Taenia solium metacestode antigens which are protective for pigs induce Th1/Th2 mixed responses in mice.

Authors:  Isabel Cortes; Jose Luis Molinari; Sandra Solano; Lilian Hernandez-Mendoza; Antonio Ramirez; Patricia Tato
Journal:  Parasitol Res       Date:  2003-03-26       Impact factor: 2.289

6.  Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.

Authors:  C Zuany-Amorim; S Hailé; D Leduc; C Dumarey; M Huerre; B B Vargaftig; M Pretolani
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice.

Authors:  I Fenoy; M Giovannoni; E Batalla; V Martin; F M Frank; I Piazzon; A Goldman
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

8.  Role of interleukin 10 in specific immunotherapy.

Authors:  C A Akdis; T Blesken; M Akdis; B Wüthrich; K Blaser
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

9.  Specific immunotherapy to birch allergen does not enhance suppression of Th2 cells by CD4(+)CD25(+) regulatory T cells during pollen season.

Authors:  Hanna Grindebacke; Pia Larsson; Kajsa Wing; Sabina Rak; Anna Rudin
Journal:  J Clin Immunol       Date:  2009-06-20       Impact factor: 8.317

Review 10.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.